Here's the live share price of Laurus Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Laurus Labs | 11.86 | 13.54 | 24.68 | 22.77 | 109.80 | 54.98 | 20.17 |
| Sun Pharmaceutical Industries | 2.16 | 7.80 | 8.37 | 8.82 | 4.59 | 24.30 | 21.48 |
| Divi's Laboratories | 3.13 | 14.07 | 9.69 | 0.25 | 12.60 | 26.85 | 10.15 |
| Torrent Pharmaceuticals | 4.41 | 8.66 | 9.53 | 14.64 | 37.49 | 37.95 | 25.91 |
| Cipla | 2.89 | 10.85 | 0.39 | -10.97 | -9.35 | 13.05 | 8.40 |
| Lupin | 3.22 | 3.68 | 8.14 | 19.65 | 18.08 | 48.09 | 14.23 |
| Dr. Reddy's Laboratories | -2.26 | 8.52 | 1.42 | 7.89 | 12.56 | 9.63 | 3.94 |
| Mankind Pharma | 8.04 | 18.85 | 16.54 | 8.54 | -0.29 | 19.45 | 11.25 |
| Zydus Lifesciences | 5.20 | 5.21 | 1.61 | -0.96 | 7.59 | 21.33 | 8.49 |
| Aurobindo Pharma | 7.12 | 11.49 | 23.91 | 29.09 | 28.51 | 33.98 | 7.28 |
| Glenmark Pharmaceuticals | -1.66 | 8.80 | 19.77 | 29.08 | 67.09 | 60.82 | 30.47 |
| Alkem Laboratories | 3.02 | 6.10 | -3.13 | -1.98 | 12.72 | 16.50 | 12.94 |
| Biocon | 5.84 | 8.73 | 1.78 | -0.44 | 13.73 | 15.93 | -0.20 |
| Abbott India | 5.70 | 3.97 | -2.18 | -8.87 | -10.47 | 6.12 | 10.79 |
| Anthem Biosciences | 3.24 | 13.71 | 16.53 | 11.25 | 7.40 | 2.41 | 1.44 |
| GlaxoSmithKline Pharmaceuticals | 6.38 | 5.52 | -1.05 | -2.19 | -9.35 | 25.36 | 11.33 |
| Ipca Laboratories | 1.64 | 7.66 | 7.21 | 15.65 | 15.26 | 30.32 | 8.34 |
| Ajanta Pharma | 7.42 | 11.97 | 6.14 | 20.05 | 20.51 | 33.42 | 17.77 |
| J B Chemicals & Pharmaceuticals | 5.26 | 10.81 | 14.42 | 18.88 | 40.27 | 27.39 | 24.79 |
| Gland Pharma | 9.02 | 10.39 | 1.26 | 1.45 | 35.05 | 11.31 | -7.34 |
Over the last one year, Laurus Labs has gained 109.80% compared to peers like Sun Pharmaceutical Industries (4.59%), Divi's Laboratories (12.60%), Torrent Pharmaceuticals (37.49%). From a 5 year perspective, Laurus Labs has outperformed peers relative to Sun Pharmaceutical Industries (21.48%) and Divi's Laboratories (10.15%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,142.37 | 1,151.07 |
| 10 | 1,126.44 | 1,134.28 |
| 20 | 1,114.94 | 1,111.33 |
| 50 | 1,058.98 | 1,072.65 |
| 100 | 1,045.13 | 1,036.24 |
| 200 | 975.33 | 958.35 |
In the latest quarter, Laurus Labs remained same as its previous close in promoter holding, while DII stake increased to 13.96%, FII holding fell to 25.82%, and public shareholding moved down to 32.73% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 93,34,006 | 2.43 | 926.59 | |
| 71,34,302 | 3.09 | 708.22 | |
| 44,68,946 | 2.74 | 443.63 | |
| 21,17,487 | 0.88 | 210.2 | |
| 18,32,618 | 6.29 | 181.92 | |
| 16,83,000 | 0.81 | 167.07 | |
| 12,82,134 | 0.92 | 127.28 | |
| 12,00,000 | 2.93 | 119.12 | |
| 11,00,000 | 1.93 | 109.2 | |
| 9,89,827 | 1.13 | 98.26 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| May 05, 2026, 11:02 PM IST IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| May 01, 2026, 03:14 AM IST IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Apr 30, 2026, 09:49 PM IST IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Apr 30, 2026, 09:12 PM IST IST | Laurus Labs - Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements)Regulations, |
| Apr 30, 2026, 09:06 PM IST IST | Laurus Labs - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements)Regulations, 2015 |
Laurus Labs Ltd. is a Public Limited Listed company incorporated on 19/09/2005 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L24239AP2005PLC047518 and registration number is 047518. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 6089.07 Cr. and Equity Capital is Rs. 107.97 Cr. for the Year ended 31/03/2026.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Laurus Labs is ₹1,229.45 as on May 08, 2026.
The Laurus Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Laurus Labs is ₹66,372.67 Cr as on May 08, 2026.
Today’s highest and lowest price of Laurus Labs are ₹1,237.75 and ₹1,206.45.
The 52-week high/low is the highest and lowest price at which Laurus Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Laurus Labs is ₹1,237.75 and 52-week low of Laurus Labs is ₹573.20 as on May 08, 2026.
The Laurus Labs has shown returns of 1.91% over the past day, 13.54% for the past month, 24.68% over 3 months, 109.8% over 1 year, 54.98% across 3 years, and 20.17% over 5 years.
P/E ratio of and PB ratio of Laurus Labs are 74.68 and 13.12 on May 08, 2026. While the company gives a dividend yield of 0.00 per annum.